Posts Tagged ‘sarcoma clinical trials’
Join us for the next session in the Sarcoma Foundation of America’s Live Expert Chat series during Sarcoma Awareness Month. On Saturday, July 18, 2020, SFA will host a panel of sarcoma experts who will discuss the latest insights on advancements in sarcoma research. Drs. Sujana Movva, Katherine Thornton, and Jonathan Trent will share their thoughts and analysis of sarcoma research efforts that were presented during the American Society for Clinical Oncology’s (ASCO) Annual Meeting in May. Webinar participants will have the opportunity to submit questions to the panel during the session. Saturday, July 18, 2020 12:00 pm EDT… Read More »
Now that many states and localities are starting to lift shelter-in-place restrictions and move into phases of reopening, what do sarcoma patients need to know? As a follow-up to our April session, the Sarcoma Foundation of America is reuniting the panel of sarcoma experts to share their thoughts on how COVID-19 may continue to impact care and what sarcoma patients need to know as we begin the phases of reopening. Our multidisciplinary panel will answer your questions and address concerns on issues of care, the impact on research and clinical trials, and next steps as we move forward. Saturday,… Read More »
In response to the COVID-19 outbreak, the Sarcoma Foundation of America (SFA) held a live, online session with a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on sarcoma patients and survivors. Panelists Brian Van Tine, MD, PhD, Washington University in St. Louis, Kurt Weiss, MD, University of Pittsburgh School of Medicine, and Breelyn Wilky, MD, University of Colorado Cancer Center, answered questions submitted by the sarcoma community. The panelists shared input on issues related to how on patients can communicate with their physicians on the risks and benefits of current care and treatment… Read More »